4 December 2020
Latham Advises the Underwriters in Silverback Therapeutics’ Initial Public Offering
Advising firms
Deal team
14 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Brian Cuneo Lead | Latham & Watkins LLP | Partner | life sciences capital markets | Bay Area |
| Phillip Stoup | Latham & Watkins LLP | Associate | life sciences capital markets | Bay Area |
| Raul Gonzalez | Latham & Watkins LLP | Associate | life sciences capital markets | Bay Area |
| Taimi Jacobson | Latham & Watkins LLP | Associate | life sciences capital markets | Bay Area |
| Christopher Hazuka | Latham & Watkins LLP | Partner | intellectual property | Bay Area |
| Robert Yeh | Latham & Watkins LLP | Associate | intellectual property | San Diego |
| Elizabeth Richards | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Counsel | regulatory | Bay Area |
| Barrett Tenbarge | Latham & Watkins LLP | Associate | regulatory | Washington, D.C. |
| Alyssa Lattner | Latham & Watkins LLP | Associate | regulatory | Washington, D.C. |
| Julie Shin | Latham & Watkins LLP | Associate | regulatory | Washington, D.C. |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Amy Feinberg | Latham & Watkins LLP | Associate | tax | Washington, D.C. |
| James Metz | Latham & Watkins LLP | Partner | benefits and compensation | Bay Area |
11 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 242m (US$241.5 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Silverback Therapeutics, Inc. (Issuer)